Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,166

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

May 31, 2007

Study Completion Date

July 31, 2008

Conditions
Advanced CancerMetastatic Cancer
Interventions
DRUG

Nadroparin calcium

Nadroparin calcium; Pre-filled syringes of 0.4 ml (3.800 anti-Xa IU), 1 subcutaneous injection/day (every 24 hours).

DRUG

saline solution (placebo)

Pre-filled syringes of 0.4 ml , 1 subcutaneous injection/day (every 24 hours).

Trial Locations (46)

10043

Medical Oncology Department San Luigi Hospital, Orbassano

10126

Oncology Department Molinette Hospital, Torino

20025

Medical Oncology Department, Legnano

20052

University Bicocca, Milan

20089

Istituto Clinico Humanitas, Rozzano

20121

Medical Oncology Department Fatebenefratelli Hospital, Milan

20122

Medical Oncology Department Policlinico, Milan

20133

Gynecology Oncology INT, Milan

20153

Medical Oncology Department San Carlo Hospital, Milan

21100

Medical Oncology Department, Varese

24047

Medical Oncology Department, Treviglio

24100

Medical Oncology Unit, Bergamo

26100

Medical Oncology Department, Cremona

27100

Salvatore Maugeri Foundation, Pavia

29100

Hematology and Oncology Department, Piacenza

35012

Medical Oncology Department, Camposampiero

35128

Medical Oncology Department Istituto Oncologico Veneto, Padua

40139

Medical Oncology Department - Bellaria Hospital, Bologna

42100

Medical Oncology Department, Reggio Emilia

44100

Medical Oncology Department, Ferrara

47100

Cancer institute of Romagna, Forlì

48100

Medical Oncology Department, Ravenna

50139

Medical Oncology Department Careggi Hospital, Florence

55100

Medical Oncology Department, Lucca

56126

Medical Oncology Department - University of Pisa, Pisa

60044

Medical Oncology Department, Fabriano

70126

Medical Oncology Department Oncology Institute, Bari

71013

Casa Sollievo dell Sofferenza, San Giovanni Rotondo

73100

Medical Oncology Department, Lecce

87100

Medical Oncology Department, Cosenza

88100

Medical Oncology Department, Catanzaro

90127

Medical Oncology Department, Palermo

98039

Medical Oncology Department, Taormina

09121

Medical Oncology Department - Businco Hospital, Cagliari

09133

Medical Oncology Department University of Cagliari, Cagliari

04100

Medical Oncology Department, Latina

06012

Medical Oncology Department, Città di Castello

06156

Medical Oncology Department, Perugia

06059

Medical Oncology Department, Todi

00135

Medical Oncology Department - S Filippo Hospital, Roma

00144

Medical Oncology Department Regina Elena Institute, Roma

Medical Oncology Department 3 Regina Elena Cancer Institute, Rome

00168

Onco-gynecology Department - Catholic University, Rome

07100

Medical Oncology Department, Sassari

05100

Medical Oncology Department, Terni

01100

Medical Oncology Department, Viterbo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Italfarmaco

INDUSTRY